Impact of Comorbidities on Mortality in Managed Care Patients With CKD

American Journal of Kidney Diseases

Volumn 48, Issue 2, 2006, Pages 212-220

  Gullion, Christina M ^a   Keith, Douglas S ^a   Nichols, Gregory A ^a   Smith, David H ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Chronic kidney disease; glomerular filtration rate; historical prospective cohort study; mortality

Indexed keywords

ADULT; AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE COURSE; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEALTH MAINTENANCE ORGANIZATION; HEART FAILURE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTERNATIONAL CLASSIFICATION OF DISEASES; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MORTALITY; PERIPHERAL VASCULAR DISEASE; PROSPECTIVE STUDY; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; SEX RATIO; SMOKING; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; COHORT STUDIES; COMORBIDITY; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; PROSPECTIVE STUDIES; SEX FACTORS;

EID: 33745913606     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2006.04.083     Document Type: Article

References (19)

1. National Kidney Foundation. K/DQOI Clinical Practice Guidelines. Am J Kidney Dis 39 suppl 1 (2002) S17-S31
2. Keith D.S., Nichols G.A., Gullion C.M., Brown J.B., and Smith D.H. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164 (2004) 659-663
3. Manjunath M., Sarnak M., and Levey A. Prediction equations to estimate glomerular filtration rate. An update. Curr Opin Nephrol Hypertens 10 (2001) 785-792
4. Kleinbaum D.G., Kupper L.L., and Morgenstern H. Epidemiologic Research. Principles and Quantitative Methods (1982), John Wiley & Sons, Inc, New York, NY
5. Hosmer D.W., and Lemeshow S. Applied Logistic Regression. (ed 2) (2000), John Wiley & Sons, Inc, New York, NY
6. Greenland S., Schwartzbaum J.A., and Finkle W.D. Problems due to small samples and sparse data in conditional logistic regression analysis. Am J Epidemiol 151 (2000) 531-539
7. Casiglia E., Mazza A., Tikhonoff V., et al. Weak effect of hypertension and other classic risk factors in the elderly who have already paid their toll. J Hum Hypertens 16 (2002) 21-31
8. Wanner C., Krane V., Marz W., et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353 (2005) 238-248
9. Levin A., Singer J., Thompson C.R., Ross H., and Lewis M. Prevalent left ventricular hypertrophy in the predialysis population. Identifying opportunities for intervention. Am J Kidney Dis 27 (1996) 347-354
10. Wheeler D.C., Townend J.N., and Landray M.J. Cardiovascular risk factors in predialysis patients. Baseline data from the Chronic Renal Impairment in Birmingham (CRIB) Study. Kidney Int Suppl 84 (2003) S201-S203
11. Levin A. Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis. Semin Dial 16 (2003) 101-105
12. Besarab A., Bolton W.K., Browne J.K., et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 339 (1998) 584-590
13. Levin A., Djurdjev O., Thompson C., et al. Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD. Am J Kidney Dis 46 (2005) 799-811
14. Jafar T.H., Schmid C.H., Landa M., et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med 135 (2001) 73-87
15. Hannedouche T., Landais P., Goldfarb B., et al. Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure. BMJ 309 (1994) 833-837
16. Del Vecchio L., Pozzi M., Salvetti A., et al. Efficacy and tolerability of manidipine in the treatment of hypertension in patients with non-diabetic chronic kidney disease without glomerular disease. Prospective, randomized, double-blind study of parallel groups in comparison with enalapril. J Nephrol 17 (2004) 261-269
17. Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., Dagenais G., and The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342 (2000) 145-153
18. US Department of Health and Human Services. A Report of the Surgeon General. The Health Benefits of Smoking Cessation (1990), US Department of Health and Human Services, Washington DC
19. Schiffl H., Lang S.M., and Fischer R. Stopping smoking slows accelerated progression of renal failure in primary renal disease. J Nephrol 15 (2002) 270-274